New patent for NOVO drug RYBELSUS

Annual Drug Patent Expirations for RYBELSUS Rybelsus is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are eight patents protecting…

The post New patent for NOVO drug RYBELSUS appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog